We serve Chemical Name:1-Chloro-2-methoxy-4-methyl-5-nitrobenzene CAS:62492-45-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-Chloro-2-methoxy-4-methyl-5-nitrobenzene
CAS.NO:62492-45-9
Synonyms:2-Chloro-5-methyl-4-nitroanisole
Molecular Formula:C8H8ClNO3
Molecular Weight:201.60700
HS Code:2909309090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:303.4ºC at 760 mmHg
Density:1.313g/cm3
Index of Refraction:1.554
PSA:55.05000
Exact Mass:201.01900
LogP:3.08840
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Chloro-5-methyl-4-nitroanisole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-5-methyl-4-nitroanisole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chloro-5-methyl-4-nitroanisole Use and application,2-Chloro-5-methyl-4-nitroanisole technical grade,usp/ep/jp grade.
Related News: The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. 1-Chloro-2-methoxy-4-methyl-5-nitrobenzene manufacturer The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. 1-Chloro-2-methoxy-4-methyl-5-nitrobenzene supplier By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. 1-Chloro-2-methoxy-4-methyl-5-nitrobenzene vendor The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency. 1-Chloro-2-methoxy-4-methyl-5-nitrobenzene factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.
